Ocumetics Grants Stock Options to Howard Group
Calgary, Alberta — March 13, 2026 — Leads & Copy —
Ocumetics Technology Corp. has granted 500,000 incentive stock options to Howard Group Inc., the corporation’s investor relations communications advisor. The options were issued as required by the agreement between Ocumetics and Howard Group, which was announced on September 12, 2025.
Each option allows Howard Group to purchase one common share of Ocumetics at an exercise price of $0.42 per share. The options are valid for two years and will vest quarterly in equal installments over twelve months. The stock options are non-transferable, and the common shares issued upon exercise will be subject to a four-month resale restriction from the date of grant.
Ocumetics Technology Corp. is a Canadian research and product development company focused on advanced vision correction solutions. The company is dedicated to enhancing the quality of life for patients through innovative research and development in ophthalmology, including state-of-the-art intraocular lenses and other vision-enhancing technologies.
Ocumetics is currently in the first-in-human early feasibility study phase of a technology for the ophthalmic industry. The company has developed an intraocular lens designed to fit within the eye’s natural lens compartment, potentially eliminating the need for corrective lenses. This lens is intended to allow the eye’s natural muscle activity to shift focus from distance to near, providing clear vision at all distances without glasses or contact lenses.
Source: Ocumetics Technology Corp.
Share this story:
